Clopra and Aminocaproic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopra (metoclopramide hydrochloride) and Aminocaproic (aminocaproic acid). Common drug interactions include adenovirus infection among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Clopra and Aminocaproic. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Aminocaproic?

Aminocaproic has active ingredients of aminocaproic acid. eHealthMe is studying from 737 Aminocaproic users. Check the latest studies of Aminocaproic.



On Jul, 11, 2026

41 people who take Clopra and Aminocaproic together, and have interactions are studied.

Clopra and Aminocaproic drug interactions.

What are the common drug interactions of Clopra and Aminocaproic, by gender? *:

female:

  1. Adenovirus infection
  2. Anaemia (lack of blood)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  6. Asthenia (weakness)
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  8. Back pain
  9. Blood cholesterol increased
  10. Blood lactic acid increased

male:

  1. Renal failure (kidney dysfunction)
  2. Multi-organ failure (multisystem organ failure)
  3. Hypoxia (low oxygen in tissues)
  4. International normalised ratio increased
  5. Mesenteric vascular insufficiency (insufficient vascular supply to mesenteric)
  6. Mitral valve disease (disease of mitral valve of heart)
  7. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  8. Pain
  9. Perineal abscess
  10. Platelet count decreased

What are the common drug interactions of Clopra and Aminocaproic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood bilirubin increased
  2. Acute respiratory distress syndrome
  3. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  4. Hypotension (abnormally low blood pressure)
  5. Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Bacterial infection
  8. Cardiac arrest
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

20-29:

  1. Abdominal infection
  2. Abdominal pain upper
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  5. Asthenia (weakness)
  6. Back pain
  7. Blood cholesterol increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bronchopleural fistula
  10. Cardiac failure congestive

30-39:

n/a

40-49:

  1. Hypertension (high blood pressure)
  2. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  3. Perineal abscess
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Anal abscess
  6. Ascites (accumulation of fluid in the abdominal cavity)
  7. Bacteraemia (presence of bacteria in the blood)
  8. Blood bilirubin increased
  9. Candida sepsis (candida in blood stream)
  10. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)

50-59:

  1. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  2. Chronic kidney disease
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal injury (kidney injury)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Headache (pain in head)
  7. Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)
  8. Renal failure (kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Subdural haematoma (blood collects between the skull and the surface of the brain)

60+:

  1. Multi-organ failure (multisystem organ failure)
  2. Renal failure (kidney dysfunction)
  3. Hypoxia (low oxygen in tissues)
  4. International normalised ratio increased
  5. Mesenteric vascular insufficiency (insufficient vascular supply to mesenteric)
  6. Mitral valve disease (disease of mitral valve of heart)
  7. Platelet count decreased
  8. Renal failure acute (rapid kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

What are the existing conditions these people have? *

  1. Pain: 17 people, 41.46%
  2. Constipation: 13 people, 31.71%
  3. High Blood Pressure: 12 people, 29.27%
  4. Anaemia (lack of blood): 10 people, 24.39%
  5. Nausea (feeling of having an urge to vomit): 10 people, 24.39%
  6. Stress And Anxiety: 8 people, 19.51%
  7. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 14.63%
  8. Cough: 6 people, 14.63%
  9. Adenovirus Infection: 5 people, 12.20%
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and Aminocaproic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clopra and Aminocaproic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aminocaproic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aminocaproic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride and aminocaproic acid (the active ingredients of Clopra and Aminocaproic, respectively), and Clopra and Aminocaproic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: